Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSStandard

POTASSIUM PHOSPHATES

POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC

Standard Dose
11.8GM/50ML (236MG/ML);11.2GM/50ML (224MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview POTASSIUM PHOSPHATES is listed in Drugs@FDA under application 217892 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC Form and strength SOLUTION;INTRAVENOUS - 11.8GM/50ML (236MG/ML);11.2GM/50ML (224MG/ML) Sponsor CIPLA Submission history Latest submission status date: 2025-01-24 00:00:00.

Structured Monograph

Clinical summary

Approval overview POTASSIUM PHOSPHATES is listed in Drugs@FDA under application 217892 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC Form and strength SOLUTION;INTRAVENOUS - 11.8GM/50ML (236MG/ML);11.2GM/50ML (224MG/ML) Sponsor CIPLA Submission history Latest submission status date: 2025-01-24 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.